128 related articles for article (PubMed ID: 33818835)
41. Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
Katsuura T; Kitajima K; Fujiwara M; Terada T; Uwa N; Noguchi K; Doi H; Tamaki Y; Yoshida R; Tsuchitani T; Fujita M; Yamakado K
Ann Nucl Med; 2018 Aug; 32(7):453-462. PubMed ID: 29858797
[TBL] [Abstract][Full Text] [Related]
42. HPV Status Improves Classification of Head and Neck Gray Zone Cancers.
Ren J; Xu W; Su J; Ren X; Bender N; Habbous S; de Almeida JR; Goldstein DP; Cheng D; Chen Z; Mirshams M; Rahini M; Huang SH; Spreafico A; Hansen A; Kim J; Waldron J; Perez-Ordonez B; Zhao Y; Hung R; Waterboer T; Liu G
J Dent Res; 2019 Jul; 98(8):879-887. PubMed ID: 31282843
[TBL] [Abstract][Full Text] [Related]
43. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
44. DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity.
Saksø M; Jensen K; Andersen M; Hansen CR; Eriksen JG; Overgaard J
Radiother Oncol; 2020 Jul; 148():65-72. PubMed ID: 32335364
[TBL] [Abstract][Full Text] [Related]
45. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced Head and Neck Cancer.
Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
[TBL] [Abstract][Full Text] [Related]
46. Eps8 expression is significantly lower in p16
Nasri E; Wiesen LB; Knapik JA; Fredenburg KM
Hum Pathol; 2018 Feb; 72():45-51. PubMed ID: 29107665
[TBL] [Abstract][Full Text] [Related]
47. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
[TBL] [Abstract][Full Text] [Related]
48. Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.
Tao Y; Aupérin A; Graff P; Lapeyre M; Grégoire V; Maingon P; Geoffrois L; Verrelle P; Calais G; Gery B; Martin L; Alfonsi M; Deprez P; Bardet E; Pignon T; Rives M; Sire C; Bourhis J
Oral Oncol; 2017 Aug; 71():61-66. PubMed ID: 28688693
[TBL] [Abstract][Full Text] [Related]
49. Is it oncologically safe to leave the ipsilateral submandibular gland during neck dissection for head and neck squamous cell carcinoma?
Ebrahim AK; Loock JW; Afrogheh A; Hille J
J Laryngol Otol; 2011 Aug; 125(8):837-40. PubMed ID: 21729447
[TBL] [Abstract][Full Text] [Related]
50. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
Gootee J; Patel M; Aurit S; Silberstein P
Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
[TBL] [Abstract][Full Text] [Related]
51. Long-term survival of head and neck squamous cell carcinoma after bone marrow transplant.
Douglas CM; Jethwa AR; Hasan W; Liu A; Gilbert R; Goldstein D; De Almedia J; Lipton J; Irish JC
Head Neck; 2020 Nov; 42(11):3389-3395. PubMed ID: 32820585
[TBL] [Abstract][Full Text] [Related]
52. Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database.
Ko HC; Chen S; Wieland AM; Yu M; Baschnagel AM; Hartig GK; Harari PM; Witek ME
Head Neck; 2017 Nov; 39(11):2159-2170. PubMed ID: 28737019
[TBL] [Abstract][Full Text] [Related]
53. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
[TBL] [Abstract][Full Text] [Related]
54. Induction chemotherapy followed by concurrent chemoradiation versus concurrent chemoradiation alone in the definitive management of p16-positive oropharyngeal squamous cell carcinoma with low-neck or N3 disease.
Bhattasali O; Han J; Thompson LDR; Buchschacher GL; Abdalla IA; Iganej S
Oral Oncol; 2018 Mar; 78():151-155. PubMed ID: 29496043
[TBL] [Abstract][Full Text] [Related]
55. A comparison of oncological outcomes between transoral surgical and non-surgical treatment protocols in the management of oropharyngeal squamous cell carcinoma.
Kao SS; Micklem J; Ofo E; Edwards S; Dhatrak D; Foreman A; Krishnan S; Hodge JC
J Laryngol Otol; 2018 Apr; 132(4):349-355. PubMed ID: 28480836
[TBL] [Abstract][Full Text] [Related]
56. Pulmonary lymphangitic carcinomatosis from head and neck squamous cell carcinoma.
Tighe D; Cavilla S; Simcock R
Int J Oral Maxillofac Surg; 2014 Jul; 43(7):806-10. PubMed ID: 24612960
[TBL] [Abstract][Full Text] [Related]
57. Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.
Zackrisson B; Kjellén E; Söderström K; Brun E; Nyman J; Friesland S; Reizenstein J; Sjödin H; Ekberg L; Lödén B; Franzén L; Ask A; Wickart-Johansson G; Lewin F; Björk-Eriksson T; Lundin E; Dalianis T; Wennerberg J; Johansson KA; Nilsson P
Radiother Oncol; 2015 Oct; 117(1):99-105. PubMed ID: 26427805
[TBL] [Abstract][Full Text] [Related]
58. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
59. Do demographics and tumour-related factors affect nodal yield at neck dissection? A retrospective cohort study.
Lim RS; Evans L; George AP; de Alwis N; Stimpson P; Merriel S; Giddings CE; Billah B; Smith JA; Safdar A; Sigston E
J Laryngol Otol; 2017 Jan; 131(S1):S36-S40. PubMed ID: 27786150
[TBL] [Abstract][Full Text] [Related]
60. Outcomes of postoperative simultaneous modulated accelerated radiotherapy for head-and-neck squamous cell carcinoma.
Moon SH; Jung YS; Ryu JS; Choi SW; Park JY; Yun T; Lee SH; Cho KH
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):140-9. PubMed ID: 20732767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
